Marcel J W Greuter

Biographic Data

ID7756721
NAMEMarcel J W Greuter
GIVEN NAMESMarcel J W
FAMILY NAMEGreuter
SIGNATUREGREUTER M J W
AFFILIATIONSUniversity Medical Center Groningen
ORCID0000-0001-5721-9159
VERIFIEDYes
TOTAL WORKS6
TOTAL CITATIONS0
WORKS AS AUTHOR6
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2020
LATEST PUBLICATION YEAR2025
H-INDEX0

  • The effect of hrHPV prevalence on cervical cancer screening strategies

    Open AccessFengming Pan, Jurjen van der Schans et al.ARTICLEBMC Public Health2025

    Our study demonstrates that the hrHPV test + VIA strategy is cost-effective both compared to no screening and VIA + colposcopy screening strategy under the optimal (70%) and realistic (8.7%) uptake scenarios, with greater cost-effectiveness at higher hrHPV prevalence levels. While VIA-based strategy is cheaper, self-sampling hrHPV test-based strategy offers greater health benefits. Implementing hrHPV testing in national screening programs at lowe…

  • High-risk human papillomavirus testing for underscreened populations

    Open AccessMarat Sultanov, Geertruida H de Bock et al.ARTICLEBMC Public Health2025

    The provided estimates can serve to inform policymakers and researchers in the context of implementing hrHPV-based screening in diverse settings

  • Early evaluation of a screen-and-treat strategy using high-risk HPV testing for Uganda

    Open AccessMarat Sultanov, Jurjen van der Schans et al.ARTICLEJournal of Global Health2024

    Background: Uganda has a high burden of cervical cancer and its current coverage of screening based on visual inspection with acetic acid (VIA) is low. High-risk HPV (hrHPV) testing is recommended by the World Health Organization as part of the global elimination strategy for cervical cancer. In this context, country-specific health economic evaluations can inform national-level decisions regarding implementation. We evaluated the recommended hrH…

  • The Role of Socio-Demographic Factors in the Coverage of Breast Cancer Screening

    Open AccessLilu Ding, Svetlana Jidkova et al.ARTICLEFrontiers in Public Health2021

    Background: In Flanders, breast cancer (BC) screening is performed in a population-based breast cancer screening program (BCSP), as well as in an opportunistic setting. Women with different socio-demographic characteristics are not equally covered by BC screening. Objective: To evaluate the role of socio-demographic characteristics on the lowest 10th and highest 90th quantile levels of BC screening coverage. Methods: The 2017 neighborhood-level c…

  • Determinants of Population-Based Cancer Screening Performance at Primary Healthcare Institutions in China

    Open AccessSenshuang Zheng, Xiaorui Zhang et al.ARTICLEInternational Journal of…2021

    Primary healthcare institutions in China perform better in colorectal than in breast and cervical cancer screening, and institutions in rural districts perform better than institutions in urban districts. Increasing the number of staff members on breast and cervical cancer screening could improve the performance of population-based cancer screening

  • Coverage determinants of breast cancer screening in Flanders

    Open AccessLilu Ding, Svetlana Jidkova et al.ARTICLEInternational Journal for Equity…2020

    Coverage rate of BC screening is not optimal in Flanders. Women with low SES that are characterized by younger age, living in a high population density area, living in crowded households, or having low dental care are less likely to be screened for BC in Flanders. If screened, they are more likely to be screened outside the BCSP